Levothyroxine (Thyroxine)

What it is

Levothyroxine is synthetic thyroxine (T4), a once-daily thyroid hormone replacement used to treat hypothyroidism. The key practical fact is that it is usually taken once daily on an empty stomach, at least 30 minutes before breakfast or tea/coffee, because food and some medicines can reduce absorption.

Levothyroxine replaces the hormone that a healthy thyroid gland normally makes. It is the standard treatment for primary hypothyroidism, and it is also used in some cases of secondary or tertiary hypothyroidism. In addition, it may be used to suppress thyroid-stimulating hormone, or TSH, in selected people after treatment for differentiated thyroid cancer, and intravenous levothyroxine can be used in severe hypothyroidism or myxedema coma.

Common brand names include Eltroxin and Thyronorm. The active ingredient is the same, but switching between manufacturers can sometimes change blood test results in sensitive patients, so clinicians often prefer consistency in the product used.

A quick comparison:

Form	Typical use	Key point
Oral tablet	Most hypothyroidism treatment	Best taken on an empty stomach
Oral liquid/soft-gel	Selected patients with absorption issues or difficulty swallowing	May be less affected by some absorption problems
Intravenous	Myxedema coma, severe hypothyroidism in hospital	Specialist use only

How it works

Levothyroxine is a manufactured form of T4, one of the two main thyroid hormones. After absorption, much of it is converted in tissues to triiodothyronine, or T3, the more active hormone at the cellular level. Thyroid hormones regulate metabolism, heart rate, temperature control, bowel function, skin and hair turnover, menstrual function, and growth and brain development in children.

When thyroid hormone levels are low, the pituitary usually raises TSH to stimulate the thyroid. Giving levothyroxine restores circulating hormone levels and, in primary hypothyroidism, usually brings TSH back toward the target range over time.

Absorption is a major issue with this drug. Levothyroxine is absorbed in the small intestine, and its bioavailability can be reduced by food, coffee, calcium, iron, some antacids, bile acid binders, and certain gastrointestinal disorders. That is why timing matters. Many patients are told to take it with water first thing in the morning and to separate it from calcium or iron supplements by several hours. This is relevant in India, where iron and calcium supplements are commonly used in pregnancy, anemia, and osteoporosis care.

Evidence and uses

Levothyroxine is the standard first-line treatment for overt hypothyroidism and has decades of clinical use behind it. It improves symptoms caused by thyroid hormone deficiency and normalizes thyroid function tests when the dose is appropriate.

Main evidence-based uses include:

1. Primary hypothyroidism due to Hashimoto thyroiditis, thyroid surgery, radioiodine treatment, or other thyroid gland failure.
2. Central hypothyroidism from pituitary or hypothalamic disease, where monitoring relies more on free T4 than TSH alone.
3. TSH suppression in selected patients with differentiated thyroid cancer.
4. Myxedema coma in hospital, using intravenous treatment.

The more debated area is subclinical hypothyroidism, where TSH is elevated but free T4 is still normal. Some people benefit, especially if TSH is clearly elevated, symptoms are present, thyroid antibodies are positive, pregnancy is planned, or cardiovascular risk is relevant. But evidence is mixed for routine treatment of mild cases, especially in older adults, and overtreatment can cause harm. Human evidence does not support using levothyroxine for weight loss in people with normal thyroid function.

Monitoring is essential because the right dose varies by age, body size, pregnancy status, cause of hypothyroidism, heart disease, and interacting medicines. Symptoms may start to improve within weeks, but blood tests often take about 6 to 8 weeks to reflect a dose change.

Safety and interactions

Levothyroxine is generally safe when the dose matches the body's needs, but too much acts like hyperthyroidism. Over-replacement can cause palpitations, tremor, anxiety, sweating, insomnia, diarrhea, and unintended weight loss. Longer-term overtreatment is linked to atrial fibrillation and reduced bone density, especially in older adults and postmenopausal women.

Important cautions include untreated adrenal insufficiency and uncorrected thyrotoxicosis. People with coronary artery disease, angina, arrhythmias, or older age often need lower starting doses and slower adjustment.

Important interactions include:

Interacting item	Effect on levothyroxine	Practical step
Calcium supplements	Lowers absorption	Separate by several hours
Iron supplements	Lowers absorption	Separate by several hours
Antacids, sucralfate	Lowers absorption	Separate dosing
Cholestyramine, colestipol, sevelamer	Strongly lowers absorption	Specialist timing advice needed
Proton pump inhibitors	May reduce absorption in some patients	Recheck thyroid tests if needed
Rifampicin, carbamazepine, phenytoin	Can increase hormone metabolism	Dose may need adjustment
Warfarin	May increase anticoagulant effect	INR may need closer monitoring
Diabetes medicines	Glucose control may change	Monitor sugars after starting or changing dose

Pregnancy deserves special attention. Levothyroxine is considered necessary and safe when prescribed for hypothyroidism in pregnancy, and dose needs often increase during pregnancy. Thyroid hormone is important for fetal development, especially early in gestation. Patients who become pregnant should contact their clinician promptly for testing and dose review.

Do not change dose, stop treatment, or switch brands repeatedly without discussing it with a clinician or pharmacist.

Diagnosis / how it's measured

Levothyroxine itself is not diagnosed; the condition it treats is monitored with blood tests. In primary hypothyroidism, the main test used for dose adjustment is TSH, often with free T4. After starting treatment or changing dose, thyroid tests are commonly repeated after about 6 to 8 weeks, because TSH takes time to stabilize.

Typical monitoring approach:

1. Confirm hypothyroidism with TSH and free T4.
2. Start levothyroxine at an individualized dose.
3. Recheck TSH, and sometimes free T4, after 6 to 8 weeks.
4. Adjust dose gradually until the target range is reached.
5. Once stable, recheck periodically, often every 6 to 12 months or sooner if symptoms, pregnancy, illness, or medicine changes occur.

In central hypothyroidism, TSH may be misleading, so clinicians rely more on free T4 and the clinical picture.

When to see a clinician

See a clinician if you have persistent hypothyroid symptoms such as fatigue, constipation, feeling cold, dry skin, heavy periods, or unexplained weight gain, especially if you already take levothyroxine. Also seek review if you develop symptoms of too much thyroid hormone, such as a racing heart, tremor, chest pain, new anxiety, or trouble sleeping.

Prompt review is important if you are pregnant, planning pregnancy, start calcium or iron supplements, begin acid-suppressing treatment, or switch to a different brand or formulation. In India and elsewhere, over-the-counter supplement use is common, so it is worth showing your full medicine and supplement list to your doctor or pharmacist.

Emergency care is needed for severe chest pain, fainting, severe shortness of breath, or signs of myxedema coma such as confusion, marked drowsiness, or hypothermia.

Limitations and open questions

Levothyroxine works very well for most patients, but not every person feels fully better even when blood tests normalize. Reasons may include anemia, depression, sleep disorders, autoimmune disease, poor absorption, inconsistent dosing, or another diagnosis rather than inadequate thyroid replacement.

Evidence is still evolving on the best approach for mild subclinical hypothyroidism, the role of liquid or soft-gel formulations in routine practice, and whether any subgroup benefits from combination T4/T3 therapy. Current evidence supports levothyroxine alone as standard care for most people, while combination therapy remains selective and specialist-led.

Another open question is how much formulation differences matter in everyday care. Most patients do well on standard tablets, but some have variable control because of gastrointestinal disease, interacting medicines, or inconsistent timing with meals. If thyroid levels remain unstable, clinicians may review adherence, timing, brand consistency, and possible malabsorption before changing treatment.